| Literature DB >> 16809150 |
Peter A Cadieux1, Sebastian A Mikolajczak, Jonathan Reeves, Craig Strathdee, Gregor Reid, Chandra J Panchal, Michael W Clarke.
Abstract
Previous studies have shown that human PSP94 can inhibit the growth of prostate cancer cells both in vitro and in vivo. To further validate this potential and investigate the protein within a homologous setting, we examined the effects of rat PSP94 on the growth of the rat prostate adenocarcinoma cell line PAIII in vitro. To generate rat PSP94, we used both a plasmid-based expression system and a recombinant rat PSP molecule. Rat PSP was shown to inhibit the growth and survival of PAIII cells in a dose-dependent manner with > 90 percent reductions in both observed. TUNEL and Annexin-V assays confirmed PAIII cell death to be via apoptosis.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16809150 DOI： 10.1080/07357900600629575
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176